Breaking News Instant updates and real-time market news.

DOCS

Doximity

$33.80 /

+0.865 (+2.63%)

08:17
05/18/22
05/18
08:17
05/18/22
08:17

Doximity price target lowered to $46 from $78 at Jefferies

Jefferies analyst Glen Santangelo lowered the firm's price target on Doximity to $46 from $78 and keeps a Buy rating on the shares. While volatility this earnings season and a recent slide in the shares had lowered expectations, investors "will view these results as disappointing," argues Santangelo, who cites seasonality and a lack of predictability relative to a pure subscription business. However, though this quarterly report is likely to impact investor perception of the business, he sees the valuation as "too attractive to ignore" based on the after-hours share price given the company's 30% revenue growth and 40% EBITDA margins that he calls "a rarity in our Digital Health group."

  • 24

    Jun

OTHER BREAKING NEWS FROM THE FLY

General news
Boris Johnson to step down as British prime minister, WSJ reports » 05:57
07/07/22
07/07
05:57
07/07/22
05:57
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$383.31 /

+1.34 (+0.35%)

Boris Johnson will step…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$383.31 /

+1.34 (+0.35%)

SPX S&P 500
/

+

07/01/22 JPMorgan
JPMorgan forecast 'perilously close' to recession after GDP cuts
06/27/22 Citi
Citi cuts S&P 500 year-end target, sees positive second half setup
05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
SPY SPDR S&P 500 ETF Trust
$383.31 /

+1.34 (+0.35%)

07/01/22 JPMorgan
JPMorgan forecast 'perilously close' to recession after GDP cuts
06/27/22 Citi
Citi cuts S&P 500 year-end target, sees positive second half setup
05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$383.31 /

+1.34 (+0.35%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$383.31 /

+1.34 (+0.35%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$383.31 /

+1.34 (+0.35%)

SPX S&P 500
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$383.31 /

+1.34 (+0.35%)

Downgrade
Segro downgraded to Underperform from Neutral at Exane BNP Paribas » 05:57
07/07/22
07/07
05:57
07/07/22
05:57
SEGXF

Segro

$11.98 /

+ (+0.00%)

Exane BNP Paribas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEGXF Segro
$11.98 /

+ (+0.00%)

07/05/22 Barclays
Segro price target lowered to 1,300 GBp from 1,545 GBp at Barclays
05/03/22 Kepler Cheuvreux
Segro downgraded to Reduce from Hold at Kepler Cheuvreux
03/31/22 Goldman Sachs
Segro downgraded to Buy from Conviction Buy at Goldman Sachs
03/23/22 JPMorgan
Segro price target raised to 1,585 GBp from 1,450 GBp at JPMorgan
Hot Stocks
Shell revises up value of oil and gas assets ahead of July 28 results » 05:56
07/07/22
07/07
05:56
07/07/22
05:56
SHEL

Shell

$48.00 /

-0.585 (-1.20%)

Shell said in a trading…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHEL Shell
$48.00 /

-0.585 (-1.20%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

07/06/22 Deutsche Bank
Shell price target raised to 2,779 GBp from 2,551 GBp at Deutsche Bank
06/09/22 Credit Suisse
Shell initiated with an Outperform at Credit Suisse
05/11/22 Morgan Stanley
Shell price target raised to 2,860 GBp from 2,570 GBp at Morgan Stanley
05/06/22 UBS
Shell price target raised to 2,550 GBp from 2,450 GBp at UBS
SHEL Shell
$48.00 /

-0.585 (-1.20%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

Downgrade
Kellogg downgraded to Neutral from Buy at UBS » 05:54
07/07/22
07/07
05:54
07/07/22
05:54
K

Kellogg

$72.73 /

+0.485 (+0.67%)

UBS analyst Cody Ross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
K Kellogg
$72.73 /

+0.485 (+0.67%)

K Kellogg
$72.73 /

+0.485 (+0.67%)

06/22/22 JPMorgan
Kellogg breakup likely doesn't alter share valuation, says JPMorgan
06/22/22 Deutsche Bank
Kellogg price target lowered to $72 from $74 at Deutsche Bank
06/22/22 Citi
Kellogg price target raised to $87 from $83 at Citi
06/21/22 Stifel
Stifel views Kellogg breakup announcement as positive for stock
K Kellogg
$72.73 /

+0.485 (+0.67%)

K Kellogg
$72.73 /

+0.485 (+0.67%)

K Kellogg
$72.73 /

+0.485 (+0.67%)

K Kellogg
$72.73 /

+0.485 (+0.67%)

Upgrade
Lamar Advertising upgraded to Buy from Neutral at Citi » 05:51
07/07/22
07/07
05:51
07/07/22
05:51
LAMR

Lamar Advertising

$88.37 /

+0.105 (+0.12%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAMR Lamar Advertising
$88.37 /

+0.105 (+0.12%)

06/10/22 Morgan Stanley
Lamar downgraded to Equal Weight on recession risk at Morgan Stanley
06/10/22 Morgan Stanley
Lamar Advertising downgraded to Equal Weight from Overweight at Morgan Stanley
03/29/22 Wolfe Research
Lamar Advertising initiated with a Peer Perform at Wolfe Research
07/19/21 Morgan Stanley
Morgan Stanley equity strategist upgrades Consumer Staples, downgrades Materials
LAMR Lamar Advertising
$88.37 /

+0.105 (+0.12%)

LAMR Lamar Advertising
$88.37 /

+0.105 (+0.12%)

Upgrade
Endeavor Group upgraded to Buy from Neutral at Citi » 05:51
07/07/22
07/07
05:51
07/07/22
05:51
EDR

Endeavor Group

$21.16 /

-0.39 (-1.81%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDR Endeavor Group
$21.16 /

-0.39 (-1.81%)

EDR Endeavor Group
$21.16 /

-0.39 (-1.81%)

07/01/22 Barclays
Endeavor Group price target raised to $28 from $27 at Barclays
06/23/22 Credit Suisse
Endeavor Group assumed with an Outperform at Credit Suisse
06/15/22 Morgan Stanley
Morgan Stanley upgrades Liberty Formula One, names Endeavor top pick
05/17/22 Goldman Sachs
Endeavor Group upgraded to Buy from Neutral at Goldman Sachs
EDR Endeavor Group
$21.16 /

-0.39 (-1.81%)

EDR Endeavor Group
$21.16 /

-0.39 (-1.81%)

EDR Endeavor Group
$21.16 /

-0.39 (-1.81%)

Periodicals
Merck in advanced talks to buy Seagen for $40B+, WSJ reports » 05:50
07/07/22
07/07
05:50
07/07/22
05:50
MRK

Merck

$93.16 /

+0.52 (+0.56%)

, SGEN

Seagen

$175.15 /

-1.78 (-1.01%)

Merck (MRK) is in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

05:10 Today Daiwa
Merck upgraded to Outperform from Neutral at Daiwa (yesterday)
07/06/22 Daiwa
Merck upgraded to Buy from Neutral at Daiwa
06/29/22 Raymond James
Seagen initiated with an Outperform at Raymond James
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
SGEN Seagen
$175.15 /

-1.78 (-1.01%)

06/29/22 Raymond James
Seagen initiated with an Outperform at Raymond James
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
06/27/22 Cowen
Merck price target raised to $102 from $95 at Cowen
06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

SGEN Seagen
$175.15 /

-1.78 (-1.01%)

MRK Merck
$93.16 /

+0.52 (+0.56%)

Periodicals
Microsoft cloud exec leaving after allegations of verbal abuse, Bloomberg says » 05:48
07/07/22
07/07
05:48
07/07/22
05:48
MSFT

Microsoft

$266.22 /

+3.35 (+1.27%)

Tom Keane, a Microsoft VP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

07/06/22 Needham
RingCentral downgraded to Hold from Buy at Needham
06/29/22 Redburn
Microsoft initiated with a Buy at Redburn
06/27/22 William Blair
Okta not seeing backlash from security breach, says William Blair
06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

MSFT Microsoft
$266.22 /

+3.35 (+1.27%)

Upgrade
1Life Healthcare upgraded to Buy from Neutral at BTIG » 05:47
07/07/22
07/07
05:47
07/07/22
05:47
ONEM

1Life Healthcare

$10.29 /

-0.07 (-0.68%)

, CVS

CVS Health

$93.20 /

+0.67 (+0.72%)

, UNH

UnitedHealth

$515.28 /

+10.54 (+2.09%)

, ELV

Elevance Health

$484.65 /

+8.295 (+1.74%)

BTIG analyst David Larsen…

BTIG analyst David Larsen upgraded 1Life Healthcare (ONEM) to Buy from Neutral with a $15 price target. Over the past two years, the stock has traded down from $60 to $10, making the multiple "far more reasonable now than it has been in the past," Larsen tells investors in a research note. The analyst also believes that the odds of 1Life being acquired are "fairly high." While the stock rallied 25% on July 5 following a Bloomberg article discussing a possible takeout, 1Life has further valuation upside potential driven by improving Medicare margins, steady membership and revenue growth, cross-sales between Medicare and Commercial, an abatement of COVID, and "well-managed" expectations, contends Larsen. He believes potential acquirers of the business include CVS Health (CVS), a large health plan such as UnitedHealth Group (UNH) or Elevance Health (ELV), or possibly a large publicly traded hospital system. A strategic takeout "seems a very real possibility," writes Larsen.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ELV Elevance Health
$484.65 /

+8.295 (+1.74%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

07/06/22 Deutsche Bank
1Life would not check 'earnings box' for CVS, says Deutsche Bank
07/06/22 Citi
Citi not seeing 'wide buyer universe' for 1Life outside of CVS
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Deutsche Bank
1Life Healthcare market cap now below last private raise, says Deutsche Bank
CVS CVS Health
$93.20 /

+0.67 (+0.72%)

07/06/22 Deutsche Bank
1Life would not check 'earnings box' for CVS, says Deutsche Bank
07/06/22 Citi
Citi not seeing 'wide buyer universe' for 1Life outside of CVS
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Loop Capital
Loop Capital starts CVS Health at Buy citing position to capitalize on Medicare
UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Loop Capital
Loop starts UnitedHealth at Buy, sees company having 'major' advantages
06/16/22 Loop Capital
UnitedHealth initiated with a Buy at Loop Capital
06/01/22 Citi
Change Healthcare price target raised to $27.75 from $25.75 at Citi
ELV Elevance Health
$484.65 /

+8.295 (+1.74%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

ONEM 1Life Healthcare
$10.29 /

-0.07 (-0.68%)

CVS CVS Health
$93.20 /

+0.67 (+0.72%)

UNH UnitedHealth
$515.28 /

+10.54 (+2.09%)

Periodicals
Shell still investing in Gulf amid climate, political debate, WSJ reports » 05:46
07/07/22
07/07
05:46
07/07/22
05:46
SHEL

Shell

$48.00 /

-0.585 (-1.20%)

, EQNR

Equinor

$32.88 /

-0.64 (-1.91%)

Shell (SHEL) is investing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

07/06/22 Deutsche Bank
Shell price target raised to 2,779 GBp from 2,551 GBp at Deutsche Bank
06/09/22 Credit Suisse
Shell initiated with an Outperform at Credit Suisse
05/11/22 Morgan Stanley
Shell price target raised to 2,860 GBp from 2,570 GBp at Morgan Stanley
05/06/22 UBS
Shell price target raised to 2,550 GBp from 2,450 GBp at UBS
EQNR Equinor
$32.88 /

-0.64 (-1.91%)

07/06/22 Deutsche Bank
Equinor price target raised to NOK 354 from NOK 314 at Deutsche Bank
06/17/22 JPMorgan
Equinor upgraded to Neutral from Underweight at JPMorgan
06/09/22 Credit Suisse
Equinor initiated with a Neutral at Credit Suisse
05/20/22 Societe Generale
Equinor downgraded to Hold from Buy at Societe Generale
SHEL Shell
$48.00 /

-0.585 (-1.20%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

SHEL Shell
$48.00 /

-0.585 (-1.20%)

EQNR Equinor
$32.88 /

-0.64 (-1.91%)

Initiation
EyePoint initiated with a Buy at Chardan » 05:43
07/07/22
07/07
05:43
07/07/22
05:43
EYPT

EyePoint

$7.78 /

-0.02 (-0.26%)

Chardan analyst Daniil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$7.78 /

-0.02 (-0.26%)

EYPT EyePoint
$7.78 /

-0.02 (-0.26%)

11/16/21 Cantor Fitzgerald
EyePoint stock movement unwarranted, says Cantor Fitzgerald
11/15/21 Cowen
EyePoint price target raised to $35 from $25 at Cowen
11/15/21 Cowen
EyePoint price target raised to $35 from $25 at Cowen
11/15/21 Guggenheim
EyePoint price target raised to $75 from $22 at Guggenheim
EYPT EyePoint
$7.78 /

-0.02 (-0.26%)

  • 17
    Nov
Upgrade
AngloGold Ashanti upgraded to Buy from Hold at Investec » 05:37
07/07/22
07/07
05:37
07/07/22
05:37
AU

AngloGold Ashanti

$14.75 /

+0.27 (+1.87%)

Investec analyst Herbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AU AngloGold Ashanti
$14.75 /

+0.27 (+1.87%)

AU AngloGold Ashanti
$14.75 /

+0.27 (+1.87%)

06/29/22 Deutsche Bank
AngloGold Ashanti price target lowered to $21 from $25 at Deutsche Bank
03/10/22 Deutsche Bank
AngloGold Ashanti price target raised to $28 from $24 at Deutsche Bank
03/07/22 JPMorgan
AngloGold Ashanti upgraded to Overweight from Neutral at JPMorgan
03/01/22 Investec
AngloGold Ashanti upgraded to Hold from Sell at Investec
Downgrade
Anglo American downgraded to Hold from Buy at Investec » 05:36
07/07/22
07/07
05:36
07/07/22
05:36
NGLOY

Anglo American

$15.87 /

+ (+0.00%)

Investec analyst Nkateko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$15.87 /

+ (+0.00%)

07/05/22 JPMorgan
Anglo American price target raised to 3,800 GBp from 3,350 GBp at JPMorgan
06/29/22 Deutsche Bank
Anglo American downgraded to Hold from Buy at Deutsche Bank
06/23/22 Morgan Stanley
Anglo American price target lowered to 3,400 GBp at Morgan Stanley
06/22/22 JPMorgan
Anglo American price target lowered to 3,350 GBp from 3,450 GBp at JPMorgan
Downgrade
Sibanye Stillwater downgraded to Hold from Buy at Investec » 05:36
07/07/22
07/07
05:36
07/07/22
05:36
SBSW

Sibanye Stillwater

$10.05 /

+0.1 (+1.01%)

Investec analyst Nkateko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBSW Sibanye Stillwater
$10.05 /

+0.1 (+1.01%)

SBSW Sibanye Stillwater
$10.05 /

+0.1 (+1.01%)

06/29/22 Deutsche Bank
Sibanye Stillwater price target lowered to $14 from $17 at Deutsche Bank
06/01/22 RBC Capital
RBC Capital cuts Sibanye Stillwater to Sector Perform on challenging environment
06/01/22 RBC Capital
Sibanye Stillwater downgraded to Sector Perform from Outperform at RBC Capital
05/09/22 Goldman Sachs
Sibanye Stillwater initiated with a Buy at Goldman Sachs
SBSW Sibanye Stillwater
$10.05 /

+0.1 (+1.01%)

Downgrade
Impala Platinum downgraded to Hold from Buy at Investec » 05:35
07/07/22
07/07
05:35
07/07/22
05:35
IMPUY

Impala Platinum

$10.58 /

-0.28 (-2.58%)

Investec analyst Nkateko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMPUY Impala Platinum
$10.58 /

-0.28 (-2.58%)

05/09/22 Goldman Sachs
Impala Platinum initiated with a Neutral at Goldman Sachs
11/17/21 Morgan Stanley
Impala Platinum upgraded to Overweight from Equal Weight at Morgan Stanley
Upgrade
Gold Fields upgraded to Buy from Hold at Investec » 05:34
07/07/22
07/07
05:34
07/07/22
05:34
GFI

Gold Fields

$9.02 /

+0.08 (+0.90%)

Investec analyst Herbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GFI Gold Fields
$9.02 /

+0.08 (+0.90%)

GFI Gold Fields
$9.02 /

+0.08 (+0.90%)

04/04/22 JPMorgan
Gold Fields downgraded to Neutral from Overweight at JPMorgan
03/21/22 UBS
UBS starts Gold Fields with Sell, says benefit's priced in
03/21/22 UBS
Gold Fields initiated with a Sell at UBS
03/17/22 BMO Capital
Gold Fields downgraded to Market Perform from Outperform at BMO Capital
GFI Gold Fields
$9.02 /

+0.08 (+0.90%)

Downgrade
Freee downgraded to Neutral from Outperform at Macquarie » 05:33
07/07/22
07/07
05:33
07/07/22
05:33
FREKF

Freee

$26.00 /

+ (+0.00%)

Macquarie analyst Hiroshi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREKF Freee
$26.00 /

+ (+0.00%)

10/22/21 Credit Suisse
Freee downgraded to Neutral from Outperform at Credit Suisse
09/01/21 Citi
Freee downgraded to Neutral from Buy at Citi
Upgrade
Cerence upgraded to Sector Perform from Underperform at RBC Capital » 05:32
07/07/22
07/07
05:32
07/07/22
05:32
CRNC

Cerence

$25.75 /

-0.385 (-1.47%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNC Cerence
$25.75 /

-0.385 (-1.47%)

CRNC Cerence
$25.75 /

-0.385 (-1.47%)

05/18/22 Northland
SoundHound replacing Cerence at Hyundai, says Northland
05/11/22 Craig-Hallum
Cerence price target lowered to $45 from $52 at Craig-Hallum
05/11/22 Wedbush
Cerence price target lowered to $32 from $45 at Wedbush
02/21/22 Goldman Sachs
Cerence downgraded to Neutral from Buy at Goldman Sachs
CRNC Cerence
$25.75 /

-0.385 (-1.47%)

CRNC Cerence
$25.75 /

-0.385 (-1.47%)

Initiation
Kalera initiated with a Buy at Roth Capital » 05:28
07/07/22
07/07
05:28
07/07/22
05:28
KAL

Kalera

$4.34 /

+1.54 (+55.00%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KAL Kalera
$4.34 /

+1.54 (+55.00%)

Upgrade
Orkla upgraded to Buy from Hold at Nordea » 05:25
07/07/22
07/07
05:25
07/07/22
05:25
ORKLY

Orkla

$8.04 /

+0.02 (+0.25%)

Nordea analyst Kristoffer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORKLY Orkla
$8.04 /

+0.02 (+0.25%)

05/19/22 Bernstein
Orkla upgraded to Outperform from Market Perform at Bernstein
05/09/22 Kepler Cheuvreux
Orkla upgraded to Buy from Hold at Kepler Cheuvreux
04/08/22 Nordea
Orkla downgraded to Hold from Buy at Nordea
04/05/22 UBS
Orkla price target lowered to NOK 73 from NOK 76 at UBS
Downgrade
Boston Beer downgraded to Sector Perform from Outperform at RBC Capital » 05:25
07/07/22
07/07
05:25
07/07/22
05:25
SAM

Boston Beer

$306.38 /

-10.87 (-3.43%)

RBC Capital analyst Nik…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

06/28/22 Goldman Sachs
Boston Beer downgraded to Sell from Neutral at Goldman Sachs
06/22/22 Bernstein
Bernstein downgrades Boston Beer to Market Perform, lowers price target to $340
06/22/22 Bernstein
Boston Beer downgraded to Market Perform from Outperform at Bernstein
06/21/22 UBS
Boston Beer downgraded to Neutral from Buy at UBS
SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

SAM Boston Beer
$306.38 /

-10.87 (-3.43%)

Upgrade
Trainline upgraded to Buy from Hold at Panmure Gordon » 05:23
07/07/22
07/07
05:23
07/07/22
05:23
TNLIF

Trainline

$3.64 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNLIF Trainline
$3.64 /

+ (+0.00%)

05/27/22 JPMorgan
Trainline price target lowered to 292 GBp from 307 GBp at JPMorgan
05/06/22 Deutsche Bank
Trainline price target raised to 319 GBp from 268 GBp at Deutsche Bank
05/06/22 Morgan Stanley
Trainline price target raised to 310 GBp from 270 GBp at Morgan Stanley
05/06/22 JPMorgan
Trainline price target raised to 307 GBp from 235 GBp at JPMorgan
Initiation
Indus Holding initiated with an Outperform at Oddo BHF » 05:23
07/07/22
07/07
05:23
07/07/22
05:23
INDHF

Indus Holding

$43.00 /

+ (+0.00%)

Oddo BHF initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Consolidated Communications downgraded to Sell from Neutral at Citi » 05:19
07/07/22
07/07
05:19
07/07/22
05:19
CNSL

Consolidated Communications

$6.98 /

-0.235 (-3.26%)

Citi analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

03/08/22 Citi
Consolidated Communications upgraded to Neutral from Sell at Citi
03/04/22 Wells Fargo
Consolidated Communications downgraded to Equal Weight from Overweight at Wells Fargo
03/04/22 Citi
Consolidated Communications downgraded to Sell from Neutral at Citi
10/29/21 Citi
Consolidated Communications upgraded to Neutral from Sell at Citi
CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

CNSL Consolidated Communications
$6.98 /

-0.235 (-3.26%)

Hot Stocks
Cognizant extends relationship with Zurich Beteiligungs-AG » 05:12
07/07/22
07/07
05:12
07/07/22
05:12
CTSH

Cognizant

$68.02 /

+0.28 (+0.41%)

Cognizant announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

05/09/22 Cowen
Cognizant price target lowered to $95 from $98 at Cowen
05/05/22 Citi
Cognizant price target lowered to $88 from $95 at Citi
02/07/22 Barclays
Cognizant price target raised to $85 from $78 at Barclays
02/03/22 BMO Capital
Cognizant price target raised to $100 from $92 at BMO Capital
CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

CTSH Cognizant
$68.02 /

+0.28 (+0.41%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.